Diabetes is a non-communicable, endocrine-related, chronic disease which has affected a large number of people around the world. In fact, the condition is believed to become so widespread that more than 40 million people won’t have access to effective medicine for Insulin, making it a major worldwide problem.
Diabetes is of two types. Type 1 diabetes needs compulsory administration of insulin as it is caused by the reduction in insulin production by the body itself. The other type of diabetes, called Type 2 diabetes, also affects a large number of people with numerous new cases coming up each year due to the urban lifestyle, the diet and the non-ambulatory work of most people. Not all cases of Type 2 diabetes need insulin; however, a significant number still do.
According to Dr. Sanjay Basu, Assistant Professor in General Medicine in Stanford University has predicted that the amount of insulin that will be manufactured and the number of expected cases by 2030 are not synonymous and there is going to be a massive shortage. Thus, a global predicament is on the cards and if immediate steps are not taken, then the crisis will be more damaging.
The study was led by Mr. Basu and his team and they extrapolated the current situation to the year 2030, so as to calculate the number of expected diabetes patients by then. Due to the ongoing lifestyle of the present generation, a significant increase in Type 2 diabetes is found to happen. More than 79 million people are expected to require insulin for the treatment; however, according to the current production, the medicine can cater to the needs of approximately 38 million people, with almost 40 million people expected to suffer from its shortage. This crisis is likely to hit Africa and Asia as well as Oceania with full force and the health sector of United Nations needs to take a timely intervention to prevent this since diabetes has been included as a priority in their list of non-communicable diseases that need to be brought under control.
Only three major manufacturers share the burden of insulin production, which makes it expensive as well. The government needs to take steps for putting more insulin in the market and making it affordable so that the global crisis can be remedied while there is still time.